World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: IRCT
Last refreshed on: 22 February 2018
Main ID:  IRCT2016111530906N1
Date of registration: 2017-02-21
Prospective Registration: No
Primary sponsor: Iran University of Medical Sciences
Public title: Studying the effect of probiotics in the prevention of urinary tract infection among elderlies
Scientific title: The effect of probiotics in the prevention of urinary tract infections in elderly patients hospitalized in intensive care units
Date of first enrolment: 2015-10-01
Target sample size: 53
Recruitment status: Complete
URL:  http://en.irct.ir/trial/24423
Study type:  interventional
Study design:  Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention.  
Phase:  2
Countries of recruitment
Iran (Islamic Republic of)
Contacts
Name: Maryam Niksolat   
Address:  Rasool Akram Hospital, Mansouri st., Sattar Khan st.,Tehran Tehran Iran (Islamic Republic of)
Telephone: +98 218052234
Email: dmniksolat@gmail.com
Affiliation:  Iran University of Medical Sciences
Name: Mahshid Talebitaher   
Address:  Rasool Akram Hospital, Mansouri st., Sattar Khan st., Tehran Tehran Iran (Islamic Republic of)
Telephone: +98 218052234
Email: mtalebitaher2000@yahoo.com
Affiliation:  Iran University of Medical Sciences
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion criteria: The inclusion criteria included elder patients who aged sixty and more, and were admitted to the ICU, and did not have any limitation for taking medicine orally; Exclusion criteria: included the patients who had a history of chemotherapy previously and right now, acute bowel obstruction, short bowel syndrome and acute pancreatitis.
Exclusion criteria:

Age minimum: 60 years
Age maximum: no limit
Gender: Both
Health Condition(s) or Problem(s) studied
Urinary tract infection, site not specified Use additional code (B95-B98), if desired, to identify infectious agent.
Prevention of Urinary Tract Infections.
Urinary tract infection, site not specified Use additional code (B95-B98), if desired, to identify infectious agent.
Intervention(s)
Intervention group: Patients in this group received probiotic capsules containing 107 × 5 CFU viable lyophilized bacteria including 4 strains of Lactobacillus (Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus Gasser and Lactobacillus Plantarm), twice a day for seven days.
Placebo
Intervention 1: Intervention group: Patients in this group received probiotic capsules containing 107 × 5 CFU viable lyophilized bacteria including 4 strains of Lactobacillus (Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus Gasser and Lactobacillus Plantarm), twice a day for seven days. Intervention 2: Control group: Patients in this group took the same shape capsules without active ingredient (placebo), twice a day for seven days.
Control group: Patients in this group took the same shape capsules without active ingredient (placebo), twice a day for seven days
Prevention
Primary Outcome(s)
Leukocyturia. Timepoint: Before intervention and a week after completion of taking the capsules. Method of measurement: Urinary analysis.
Urinary tract infection. Timepoint: Before intervention and a week after completion of taking the capsules. Method of measurement: urinary culture.
Secondary Outcome(s)
Mortality. Timepoint: On 30th day of intervention. Method of measurement: Followed up by phone call.
Secondary ID(s)
Source(s) of Monetary Support
Iran University of Medical Sciences
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Ethics committee of Iran University of Medical Sciences
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history